Bausch Health Companies Inc
XMUN:BVF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bausch Health Companies Inc
XMUN:BVF
|
CA |
|
Eagle Bancorp Montana Inc
NASDAQ:EBMT
|
US |
|
Easterly Government Properties Inc
F:E050
|
US |
|
J
|
JAFCO Group Co Ltd
XHAM:JAF
|
JP |
|
Centrale del Latte d'Italia SpA
MIL:CLI
|
IT |
|
C
|
Columbus McKinnon Corp
F:VC3
|
US |
|
A
|
Alps Alpine Co Ltd
DUS:ALE
|
JP |
|
B
|
BayWa AG
XMUN:BYW6
|
DE |
|
Xeris Biopharma Holdings Inc
F:2B30
|
US |
|
Rolta India Ltd
BSE:500366
|
IN |
|
S
|
Spok Holdings Inc
F:FQV
|
US |
|
RENERGEN Ltd
OTC:RGNTF
|
ZA |
|
M
|
Minth Group Ltd
OTC:MNTHY
|
CN |
|
E
|
Electro Optic Systems Holdings Ltd
OTC:EOPSF
|
AU |
|
R
|
Reading International Inc
F:46B
|
US |
Wall St Price Targets
BVF Price Targets Summary
Bausch Health Companies Inc
According to Wall Street analysts, the average 1-year price target for BVF is 5.68 EUR with a low forecast of 5.624 EUR and a high forecast of 5.847 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BVF's stock price target?
Price Target
5.68
EUR
According to Wall Street analysts, the average 1-year price target for BVF is 5.68 EUR with a low forecast of 5.624 EUR and a high forecast of 5.847 EUR.
What is the Revenue forecast for Bausch Health Companies Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 7 years is 0%.
What is the Operating Income forecast for Bausch Health Companies Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 7 years is 5%.
What is the Net Income forecast for Bausch Health Companies Inc?
Projected CAGR
39%
The compound annual growth rate for Net Income over the next 7 years is 39%.
